Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Journal of Diabetes Research
Volume 2014, Article ID 717219, 8 pages
http://dx.doi.org/10.1155/2014/717219
Research Article

The Effect of Chromium Picolinate Supplementation on the Pancreas and Macroangiopathy in Type II Diabetes Mellitus Rats

Shanghai Tong Ren Hospital Affiliated to Shanghai Jiaotong University Medical School, Xianxia Road No. 1111, Changning District, Shanghai 200336, China

Received 27 February 2014; Revised 22 April 2014; Accepted 22 April 2014; Published 25 June 2014

Academic Editor: Aristidis Veves

Copyright © 2014 Shan Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hjelmesaeth, A. Hartmann, T. Leivestad et al., “The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events,” Kidney International, vol. 69, no. 3, pp. 588–595, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. M. Choi, P. Ilankumaran, H. W. Kim et al., “Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders,” Google Patents, 2008.
  3. U. Nöthlings, H. Boeing, G. Maskarinec et al., “Food intake of individuals with and without diabetes across different countries and ethnic groups,” European Journal of Clinical Nutrition, vol. 65, no. 5, pp. 635–641, 2011. View at Google Scholar
  4. E. Ritz and S. R. Orth, “Nephropathy in patients with type 2 diabetes mellitus,” The New England Journal of Medicine, vol. 341, no. 15, pp. 1127–1133, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Krugner-Higby, M. Shadoan, C. Carlson et al., “Type 2 diabetes mellitus, hyperlipidemia, and extremity lesions in California mice (Peromyscus californicus) fed commercial mouse diets,” Comparative Medicine, vol. 50, no. 4, pp. 412–418, 2000. View at Google Scholar · View at Scopus
  6. M. Yamamoto, G. Egusa, M. Okubo, and M. Yamakido, “Dissociation of microangiopathy and macroangiopathy in patients with type 2 diabetes,” Diabetes Care, vol. 21, no. 9, pp. 1451–1454, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Tsukada, E. Sekizuka, C. Oshio, and H. Minamitani, “Direct measurement of erythrocyte deformability in diabetes mellitus with a transparent microchannel capillary model and high-speed video camera system,” Microvascular Research, vol. 61, no. 3, pp. 231–239, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. B. Harris, J. Ekoé, Y. Zdanowicz, and S. Webster-Bogaert, “Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study),” Diabetes Research and Clinical Practice, vol. 70, no. 1, pp. 90–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Strojek, “Features of macrovascular complications in type 2 diabetic patients,” Acta Diabetologica, vol. 40, no. 2, pp. S334–S337, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Anderson, N. Cheng, N. A. Bryden et al., “Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes,” Diabetes, vol. 46, no. 11, pp. 1786–1791, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Zhao, X. Hu, Q. Guo et al., “Physicochemical properties and regulatory effects on db/db diabetic mice of β-glucans extracted from oat, wheat and barley,” Food Hydrocoll, vol. 37, pp. 60–68, 2014. View at Google Scholar
  12. K. H. Sumrall and J. B. Vincent, “Is glucose tolerance factor an artifact produced by acid hydrolysis of low-molecular-weight chromium-binding substance?” Polyhedron, vol. 16, no. 23, pp. 4171–4177, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Sreejayan, F. Dong, M. R. Kandadi, X. Yang, and J. Ren, “Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice,” Obesity, vol. 16, no. 6, pp. 1331–1337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Toghyani, M. Toghyani, M. Shivazad, A. Gheisari, and R. Bahadoran, “Chromium supplementation can alleviate the negative effects of heat stress on growth performance, carcass traits, and meat lipid oxidation of broiler chicks without any adverse impacts on blood constituents,” Biological Trace Element Research, vol. 146, no. 2, pp. 171–180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. M. Davis and J. B. Vincent, “Chromium in carbohydrate and lipid metabolism,” Journal of Biological Inorganic Chemistry, vol. 2, no. 6, pp. 675–679, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Tsapakos and K. E. Wetterhahn, “The interaction of chromium with nucleic acids,” Chemico-Biological Interactions, vol. 46, no. 2, pp. 265–277, 1983. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Mikalsen, J. Alexander, H. Wallin, M. Ingelman-Sundberg, and R. A. Andersen, “Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes,” Carcinogenesis, vol. 12, no. 5, pp. 825–831, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. H. C. Lukaski, “Chromium as a supplement,” Annual Review of Nutrition, vol. 19, pp. 279–302, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. G. J. Ryan, N. S. Wanko, A. R. Redman, and C. B. Cook, “Chromium as adjunctive treatment for type 2 diabetes,” Annals of Pharmacotherapy, vol. 37, no. 6, pp. 876–885, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M.-Q. Wang, H. Li, Y.-D. He, C. Wang, W. Tao, and Y. Du, “Efficacy of dietary chromium (III) supplementation on tissue chromium deposition in finishing pigs,” Biological Trace Element Research, vol. 148, no. 3, pp. 316–321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. W. T. Cefalu, J. Rood, P. Pinsonat et al., “Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus,” Metabolism: Clinical and Experimental, vol. 59, no. 5, pp. 755–762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Martin, Z. Q. Wang, X. H. Zhang et al., “Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes,” Diabetes Care, vol. 29, no. 8, pp. 1826–1832, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Dronavalli, I. Duka, and G. L. Bakris, “The pathogenesis of diabetic nephropathy,” Nature Clinical Practice Endocrinology & Metabolism, vol. 4, no. 8, pp. 444–452, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. P. Hermans, S. A. Ahn, and M. F. Rousseau, “The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetes,” Journal of Diabetes and its Complications, vol. 26, no. 3, pp. 187–194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Nylander and S. Svartholm, “Self care activities of patients with Diabetes Mellitus Type 2 in Ho Chi Minh City,” 2010.
  26. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Fujita, S. Hemmi, M. Kajiwara et al., “Complement-mediated chronic inflammation is associated with diabetic microvascular complication,” Diabetes/Metabolism Research and Reviews, vol. 29, no. 3, pp. 220–226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Roesen, P. Ferber, and D. Tschoepe, “Macrovascular disease in diabetes: current status,” Experimental and Clinical Endocrinology and Diabetes, vol. 109, supplement 2, pp. S474–S486, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Sahin, M. Tuzcu, C. Orhan et al., “Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin,” British Journal of Nutrition, vol. 110, no. 2, pp. 197–205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Szkudelski, “The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas,” Physiological Research, vol. 50, no. 6, pp. 537–546, 2001. View at Google Scholar · View at Scopus
  31. T. A. Buchanan, A. H. Xiang, R. K. Peters et al., “Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women,” Diabetes, vol. 51, no. 9, pp. 2796–2803, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. D.-S. Kim, T.-W. Kim, and J.-S. Kang, “Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats,” Journal of Trace Elements in Medicine and Biology, vol. 17, no. 4, pp. 243–247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. D.-S. Kim, T.-W. Kim, I.-K. Park, J.-S. Kang, and A.-S. Om, “Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats,” Metabolism: Clinical and Experimental, vol. 51, no. 5, pp. 589–594, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. I. M. Stratton, A. I. Adler, H. A. W. Neil et al., “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study,” British Medical Journal, vol. 321, no. 7258, pp. 405–412, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Del Turco and G. Basta, “An update on advanced glycation endproducts and atherosclerosis,” BioFactors, vol. 38, no. 4, pp. 266–274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Nam and R. Fettiplace, “Optimal electrical properties of outer hair cells ensure cochlear amplification,” PLoS ONE, vol. 7, no. 11, Article ID e50572, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Jakuš, E. Sándorová, J. Kalninová, and B. Krahulec, “Monitoring of glycation, oxidative stress and inflammation in relation to the occurrence of vascular complications in patients with type 2 diabetes mellitus,” Physiological Research, 2014. View at Google Scholar
  38. D. Zozuliñska and B. Wierusz-Wysocka, “Hyperglycaemia and inflammation are culpritis of late diabetic complications,” Archives of Medical Science, vol. 1, pp. 115–118, 2005. View at Google Scholar
  39. A. Hirata, K. Kishida, H. Nakatsuji, H. Kobayashi, T. Funahashi, and I. Shimomura, “High serum C1q-adiponectin/total adiponectin ratio correlates with coronary artery disease in Japanese type 2 diabetics,” Metabolism: Clinical and Experimental, vol. 62, no. 4, pp. 578–585, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Xiao, L. Yao, X. Li et al., “Relationship of adipocyte fatty acid-binding protein to adiponectin ratio with femoral intima-media thickness and endothelium-dependent vasodilation in patients with newly-diagnosed type 2 diabetes mellitus,” Zhonghua Yi Xue Za Zhi, vol. 90, no. 4, pp. 231–235, 2010. View at Google Scholar · View at Scopus
  41. A. R. Saltiel and C. R. Kahn, “Insulin signalling and the regulation of glucose and lipid metabolism,” Nature, vol. 414, no. 6865, pp. 799–806, 2001. View at Publisher · View at Google Scholar · View at Scopus